Depreciation in USD of Cue Biopharma, Inc. from Q1 2017 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Cue Biopharma, Inc. quarterly and annual Depreciation history and change rate from Q1 2017 to Q3 2025.
  • Cue Biopharma, Inc. Depreciation for the quarter ending 30 Sep 2025 was $76,000, a 22% decline year-over-year.
  • Cue Biopharma, Inc. Depreciation for the twelve months ending 30 Sep 2025 was $362,000, a 22% decline year-over-year.
  • Cue Biopharma, Inc. annual Depreciation for 2024 was $385,000, a 29% decline from 2023.
  • Cue Biopharma, Inc. annual Depreciation for 2023 was $545,000, a 34% decline from 2022.
  • Cue Biopharma, Inc. annual Depreciation for 2022 was $831,000, a 8.6% decline from 2021.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Cue Biopharma, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $362,000 $76,000 -$21,000 -22% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $383,000 $97,000 -$3,000 -3% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 $386,000 $97,000 +$1,000 +1% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 $385,000 $92,000 -$79,000 -46% 01 Oct 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
Q3 2024 $464,000 $97,000 -$3,000 -3% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025 2025 Q3
Q2 2024 $467,000 $100,000 $0 0% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2025 Q2
Q1 2024 $467,000 $96,000 -$78,000 -45% 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1
Q4 2023 $545,000 $171,000 -$30,000 -15% 01 Oct 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 $575,000 $100,000 -$98,000 -49% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024 2024 Q3
Q2 2023 $673,000 $100,000 -$112,000 -53% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024 2024 Q2
Q1 2023 $785,000 $174,000 -$46,000 -21% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024 2024 Q1
Q4 2022 $831,000 $201,000 -$27,114 -12% 01 Oct 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 $858,114 $198,000 -$34,000 -15% 01 Jul 2022 30 Sep 2022 10-Q 03 Nov 2023 2023 Q3
Q2 2022 $892,114 $212,000 -$19,000 -8.2% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023 2023 Q2
Q1 2022 $911,114 $220,000 +$2,000 +0.92% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023 2023 Q1
Q4 2021 $909,114 $228,114 +$42,585 +23% 01 Oct 2021 31 Dec 2021 10-K 21 Mar 2023 2022 FY
Q3 2021 $866,529 $232,000 +$33,000 +17% 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022 2022 Q3
Q2 2021 $833,529 $231,000 +$29,000 +14% 01 Apr 2021 30 Jun 2021 10-Q 04 Aug 2022 2022 Q2
Q1 2021 $804,529 $218,000 +$24,000 +12% 01 Jan 2021 31 Mar 2021 10-Q 10 May 2022 2022 Q1
Q4 2020 $780,529 $185,529 -$9,585 -4.9% 01 Oct 2020 31 Dec 2020 10-K 16 Mar 2022 2021 FY
Q3 2020 $790,114 $199,000 +$5,000 +2.6% 01 Jul 2020 30 Sep 2020 10-Q 09 Nov 2021 2021 Q3
Q2 2020 $785,114 $202,000 -$3,000 -1.5% 01 Apr 2020 30 Jun 2020 10-Q 09 Aug 2021 2021 Q2
Q1 2020 $788,114 $194,000 -$11,000 -5.4% 01 Jan 2020 31 Mar 2020 10-Q 10 May 2021 2021 Q1
Q4 2019 $799,114 $195,114 -$7,897 -3.9% 01 Oct 2019 31 Dec 2019 10-K 09 Mar 2021 2020 FY
Q3 2019 $807,011 $194,000 -$1,000 -0.51% 01 Jul 2019 30 Sep 2019 10-Q 09 Nov 2020 2020 Q3
Q2 2019 $808,011 $205,000 +$10,000 +5.1% 01 Apr 2019 30 Jun 2019 10-Q 07 Aug 2020 2020 Q2
Q1 2019 $798,011 $205,000 +$38,000 +23% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020 2020 Q1
Q4 2018 $760,011 $203,011 01 Oct 2018 31 Dec 2018 10-K 12 Mar 2020 2019 FY
Q3 2018 $195,000 01 Jul 2018 30 Sep 2018 10-Q 07 Nov 2019 2019 Q3
Q2 2018 $195,000 01 Apr 2018 30 Jun 2018 10-Q 08 Aug 2019 2019 Q2
Q1 2018 $167,000 +$100,000 +149% 01 Jan 2018 31 Mar 2018 10-Q 08 May 2019 2019 Q1
Q1 2017 $67,000 01 Jan 2017 31 Mar 2017 10-Q 14 May 2018 2018 Q1

Cue Biopharma, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $385,000 -$160,000 -29% 01 Jan 2024 31 Dec 2024 10-K 31 Mar 2025 2024 FY
2023 $545,000 -$286,000 -34% 01 Jan 2023 31 Dec 2023 10-K 31 Mar 2025 2024 FY
2022 $831,000 -$78,114 -8.6% 01 Jan 2022 31 Dec 2022 10-K 28 Mar 2024 2023 FY
2021 $909,114 +$128,585 +16% 01 Jan 2021 31 Dec 2021 10-K 21 Mar 2023 2022 FY
2020 $780,529 -$18,585 -2.3% 01 Jan 2020 31 Dec 2020 10-K 16 Mar 2022 2021 FY
2019 $799,114 +$39,103 +5.1% 01 Jan 2019 31 Dec 2019 10-K 09 Mar 2021 2020 FY
2018 $760,011 +$340,443 +81% 01 Jan 2018 31 Dec 2018 10-K 12 Mar 2020 2019 FY
2017 $419,568 01 Jan 2017 31 Dec 2017 10-K 14 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.